Transformation of Black Phosphorus through Lattice Reconstruction for NIR-II-Responsive Cancer Therapy.
Transformation of Black Phosphorus through Lattice Reconstruction for NIR-II-Responsive Cancer Therapy.
复制标题
DOI:
10.1002/advs.202305762
复制
发表时间:
2024-01
期刊:
影响因子:
15.1
通讯作者:
Yu, Xue-Feng
中科院分区:
文献类型:
--
作者:
Wu, Lie;Jiang, Mingyang;Chu, Chenchen;Luo, Tingting;Hui, Yun;Zhou, Wenhua;Geng, Shengyong;Yu, Xue-Feng
The photothermal performance of black phosphorus (BP) in the near infrared (NIR)‐II bio‐window (1000–1500 nm) is low, which limits its biomedical applications. Herein, ultrasmall nickel phosphide quantum dots (Ni2P QDs) are synthesized with BP quantum dots (BPQDs) as the template by topochemical transformation. The size of Ni2P QDs is ≈3.5 nm, similar to that of BPQDs, whereas the absorption and photothermal conversion efficiency of Ni2P QDs at 1064 nm (43.5%) are significantly improved compared with those of BPQDs. To facilitate in vivo applications, an Ni2P QDs‐based liposomal nano‐platform (Ni2P‐DOX@Lipo‐cRGD) is designed by incorporation of Ni2P QDs and doxorubicin (DOX) into liposomal bilayers and the interior, respectively. The encapsulated DOX is responsively released from liposomes upon 1064‐nm laser irradiation owing to the photothermal effect of Ni2P QDs, and the drug release rate and amount are controlled by the light intensity and exposure time. In vivo, experiments show that Ni2P‐DOX@Lipo‐cRGD has excellent tumor target capability and biocompatibility, as well as complete tumor ablation through the combination of photothermal therapy and chemotherapy. The work provides a new paradigm for the NIR‐II transformation of nano‐materials and may shed light on the construction of multifunctional nano‐platforms for cancer treatment. NIR‐I‐responsive black phosphorus quantum dots are topochemically transformed to NIR‐II‐responsive nickel phosphide quantum dots (Ni2P QDs) through lattice reconstruction, which are embedded into liposomal bilayers to construct an anti‐cancer nanoplatform (Ni2P‐DOX@Lipo‐cRGD). Targeted delivery, on‐demand drug release, and complete tumor ablation are realized by Ni2P‐DOX@Lipo‐cRGD.
登录
查看更多内容
影响因子:
8.6
作者:
Wang, Fei;Yuan, Zhenwei;Chen, Haiyan
通讯作者:
Chen, Haiyan
影响因子:
9.5
作者:
Xie, Chang;Wang, Li;Yang, Shangfeng
通讯作者:
Yang, Shangfeng
影响因子:
3.3
作者:
Lam, Adrian K. Y.;Li, Cong;da Silva, Gabriel
通讯作者:
da Silva, Gabriel
影响因子:
17.1
作者:
Zhao, Yinan;Zhao, Tianyi;Zhang, Shubiao
通讯作者:
Zhang, Shubiao
影响因子:
6.7
作者:
Yin, Mengyuan;Chen, Xiangcun;Wang, Xianwen
通讯作者:
Wang, Xianwen